Combining Asthma Treatments Works Best for Daily Control and Relieving Attacks, AHRQ-Supported Study Finds
When treating persistent asthma in patients older than 12, using a corticosteroid and a long-acting bronchodilator for both daily asthma control and relief during asthma attacks is more effective than using different medications, according to an AHRQ-supported article inJAMA. Treatment guidelines currently suggest using an inhaled corticosteroid, with or without a long-acting bronchodilator, for daily control, and a different medication (short-acting beta-agonist, albuterol) for rescue relief. Researchers found that using the same combination therapy for both asthma control and for relief resulted in significantly fewer asthma attacks, hospitalizations and emergency room visits. Differences in harms were not evaluated, however. The findings are based on a new AHRQ-supported evidence review, Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma.